Long term efficacy: Idebenone reduces the rate of both inspiratory and expiratory functional loss in Duchenne muscular dystrophy (DMD)

O. Mayer (Philadelphia, United States of America), M. Leinonen (Pratteln, Switzerland), S. Hasham (Pratteln, Switzerland), G. Buyse On Behalf Of The Syros Investigators (Leuven, Belgium)

Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Session: Rare and ultra-rare diseases and the lungs: updates and new perspectives
Session type: Oral Presentation
Number: 5331
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Mayer (Philadelphia, United States of America), M. Leinonen (Pratteln, Switzerland), S. Hasham (Pratteln, Switzerland), G. Buyse On Behalf Of The Syros Investigators (Leuven, Belgium). Long term efficacy: Idebenone reduces the rate of both inspiratory and expiratory functional loss in Duchenne muscular dystrophy (DMD). 5331

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evolution of pulmonary function in children with Duchenne muscular dystrophy: implication of expiratory muscles
Source: Eur Respir J 2005; 26: Suppl. 49, 499s
Year: 2005

Efficacy of Idebenone in respiratory decline in Duchenne muscular dystrophy (DMD): Comparison of analysis methods
Source: International Congress 2017 – New ideas for the management of chronic lung diseases
Year: 2017



Evaluating the effect of long-term idebenone treatment on respiratory morbidity in patients with Duchenne muscular dystrophy (DMD)
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019




Meta-analysis of two clinical trials: Slowing respiratory decline in Duchenne muscular dystrophy (DMD)
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

Effects of idebenone on pulmonary morbidity in Duchenne muscular dystrophy (DMD)
Source: International Congress 2017 – New ideas for the management of chronic lung diseases
Year: 2017



Inspiratory and expiratory muscle weakness in facioscapulohumeral muscular dystrophy
Source: International Congress 2019 – Lung function and respiratory muscle testing
Year: 2019

Home-based versus hospital monitoring of respiratory function changes in Duchenne muscular dystrophy (DMD)
Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction
Year: 2018

Sleep in patients with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA): is there a difference?
Source: Eur Respir J 2001; 18: Suppl. 33, 88s
Year: 2001

Thoraco-abdominal asynchronies during spontaneous breathing in Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012

Inefficient cough in Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012

Effects of posture on peak cough flow and respiratory muscle activation in Duchenne muscular dystrophy
Source: International Congress 2018 – New insights in testing lung and respiratory muscle functions
Year: 2018

Which are the most informative parameters to follow the respiratory decline in Duchenne muscular dystrophy?
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012

Respiratory kinematics in Duchenne muscular dystrophy (DMD)
Source: Eur Respir J 2007; 30: Suppl. 51, 376s
Year: 2007

Effects of air stacking on peak cough flows (PCFs) and forced vital capacities (FVCs) in patients with Duchenne muscular dystrophy
Source: Annual Congress 2007 - Respiratory muscles and breathing techniques in obstructive and neuromuscular diseases
Year: 2007


Sniff nasal inspiratory pressure in the longitudinal assessment of young Duchenne muscular dystrophy children
Source: Eur Respir J 2013; 42: 671-680
Year: 2013



The natural course of lung volumes in Duchenne Muscular Dystrophy (DMD)
Source: International Congress 2017 – Assessing the impact of respiratory and sleep problems in children
Year: 2017

Abdominal volume contribution to tidal volume as an early indicator of respiratory impairment in Duchenne muscular dystrophy
Source: Eur Respir J 2010; 35: 1118-1125
Year: 2010



Earlier decline in sniff nasal inspiratory pressure than peak expiratory flow in children with Duchenne muscular dystrophy
Source: Eur Respir J 2014; 44: 1361-1363
Year: 2014


Assessment of diaphragm thickness variations by ultrasonography in patients with Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012

Abdominal volume contribution to tidal volume as an early indicator of respiratory impairment in duchenne muscular dystrophy (dmd)
Source: Annual Congress 2009 - Exciting studies with old and new lung function tests
Year: 2009